http://aloxi.legalview.com/msn/ 2012-02-23 http://aloxi.legalview.com/msn/tech-stock-movers-is-pharma-clyde-process-solutions-enrc-dana-ithaca-e/1236126/ 2012-02-23 http://aloxi.legalview.com/msn/nausea-drug-helps-helsinn-birexs-irish-arm-to-double-profits/1198183/ 2012-02-23 http://aloxi.legalview.com/msn/clinical-study-shows-promising-approach-for-preventing-chemotherapy-in/1198182/ 2012-02-23 http://aloxi.legalview.com/msn/helsinn-healthcare-sa-and-eisai-inc-extend-relationship/1198181/ 2012-02-23 http://aloxi.legalview.com/msn/phase-iii-trial-shows-addition-of-a-new-agent-causes-big-reduction-in/1110419/ 2012-02-23 http://aloxi.legalview.com/msn/ap-pharmas-product-candidate-for-chemotherapy-induced-nausea-gets/1110418/ 2012-02-23 http://aloxi.legalview.com/msn/ap-pharma-reports-second-quarter-2009-financial-results/1110417/ 2012-02-23 http://aloxi.legalview.com/msn/new-drug-may-work-better-against-chemo-side-effects/1110416/ 2012-02-23 http://aloxi.legalview.com/msn/in-the-know/1110415/ 2012-02-23 http://aloxi.legalview.com/msn/midas-share-tips-international-ferro-metals-is-pharma/1110414/ 2012-02-23 http://aloxi.legalview.com/msn/ap-pharma-inc-appa-reveals-positive-phase-iii-results-for/1110413/ 2012-02-23 http://aloxi.legalview.com/msn/single-dose-palonosetron-prevents-emesis-induced-by-chemotherapy-in/1110412/ 2012-02-23 http://aloxi.legalview.com/msn/ap-pharma-announces-fda-acceptance-of-apf530-new-drug-application/1110411/ 2012-02-23